Video Experimental Relacionado
Updated: Jul 6, 2026
11:26
High-throughput Gene Tagging in Trypanosoma brucei
Published on: August 12, 2016
Un transportador de nucleósidos de Trypanosoma brucei involucrado en la resistencia a los medicamentos
P Mäser1, C Sütterlin, A Kralli
1Swiss Tropical Institute, CH-4002 Basel, Switzerland. Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Science (New York, N.Y.)
|July 10, 1999
Resumen
La resistencia a los medicamentos en la enfermedad del sueño es una preocupación creciente. Los investigadores identificaron un gen específico (TbAT1) responsable de la absorción de fármacos en el Trypanosoma brucei, lo que ofrece nuevas vías para el tratamiento de infecciones resistentes.
Área de la Ciencia:
- Parasitología Parasitología.
- Biología Molecular Biología Molecular
- Descubrimiento de Drogas Descubrimiento de Drogas
Sus antecedentes:
- La resistencia a los fármacos en los patógenos es un desafío de salud global significativo y mal entendido.
- La captación celular de los principales fármacos para la enfermedad del sueño (Trypanosoma brucei spp.) está vinculado a un transportador de adenosina no identificado.
- La comprensión de los mecanismos de transporte de drogas es crucial para combatir las infecciones resistentes.
Objetivo del estudio:
- Para identificar el gen específico responsable de la absorción de fármacos en el Trypanosoma brucei.
- Investigar el papel de este gen en la susceptibilidad y resistencia a los medicamentos.
- Explorar posibles estrategias diagnósticas y terapéuticas para la enfermedad del sueño resistente a los medicamentos.
Principales métodos:
- Cribado funcional en Saccharomyces cerevisiae para clonar un gen transportador de nucleósidos (TbAT1) de Trypanosoma brucei brucei.
- Expresar el gen TbAT1 clonado en levadura para evaluar su función.
- Analizando las variantes de TbAT1 en cepas de tripanosomas resistentes a los fármacos.
Principales resultados:
- Un gen transportador de nucleósidos, TbAT1, fue clonado con éxito de Trypanosoma brucei brucei.
- La expresión de TbAT1 en la levadura facilitó la absorción de adenosina y aumentó la susceptibilidad a los arsenicales de melaminofenilo.
- Se encontró que los tripanosomas resistentes a los medicamentos poseían una variante defectuosa de TbAT1, lo que indica su papel en la resistencia.
Conclusiones:
- La identificación molecular de TbAT1 como la ruta de entrada del fármaco proporciona un objetivo para comprender y combatir la resistencia a los fármacos.
- Este descubrimiento allana el camino para el desarrollo de nuevas herramientas de diagnóstico y tratamientos para la enfermedad del sueño, particularmente en casos de resistencia a los medicamentos.
Más Videos Relacionados
09:45Detection of Trypanosoma brucei Variant Surface Glycoprotein Switching by Magnetic Activated Cell Sorting and Flow Cytometry
Published on: October 19, 2016
14:26Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)
Published on: April 6, 2019
Videos de Conceptos Relacionados
03:08LTR Retrotransposons
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
01:31ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
01:16Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
01:28Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...